Published in Acta Neuropathol on January 01, 1989
A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo. Immunology (1994) 0.85
Significance of degenerating endoneurial cells in peripheral neuropathy. Acta Neuropathol (1991) 0.85
Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry (1994) 0.85
Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG. J Neuroimmunol (2007) 0.79
Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry (2003) 0.79
Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies. J Immunol Res (2015) 0.78
The structure of two IgMs showing different activity from a patient with Waldenstrom's macroglobulinaemia. Clin Exp Immunol (1992) 0.75
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction. J Cell Biol (1987) 1.85
Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain (1983) 1.50
Waldenström's macroglobulinemia and neuropathy. Deposition of M-component on myelin sheaths. Neurology (1975) 1.47
Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol (1978) 1.35
Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology (1983) 1.33
Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol (1987) 1.20
Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol (1985) 1.20
A rapid procedure for selectively isolating the major glycoprotein from purified rat brain myelin. Biochem J (1977) 1.19
Polyneuropathy in Waldenström's macroglobulinaemia. J Neurol Sci (1974) 1.18
[Neurological manifestations in monoclonal gammapathies. Pure neurological manifestations. Immunofluorescence study]. Rev Neurol (Paris) (1976) 1.12
Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol (1984) 1.07
Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein. Neurology (1983) 1.04
The occurrence and significance of myelin with unusually large periodicity. Acta Neuropathol (1984) 0.99
Chronic demyelinating neuropathy with IgM-producing lymphocytes in peripheral nerve and delayed appearance of "benign" monoclonal gammopathy. Neurology (1984) 0.99
Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia. Neurology (1982) 0.98
[Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy]. Rev Neurol (Paris) (1988) 0.98
Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology (1988) 0.97
Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol (1984) 0.94
Mononeuritis multiplex in Waldenström's macroglobulinemia. Ann Neurol (1987) 0.93
IgM-producing lymphocytes in peripheral nerve in a patient with benign monoclonal gammopathy. Scand J Haematol (1973) 0.93
[Peripheral neuropathies i- Waldenstrom's disease. Histological and ultrastructural studies of 5 cases]. Ann Anat Pathol (Paris) (1976) 0.91
Neuropathy, amyloidosis, and monoclonal gammopathy. J Neurol Neurosurg Psychiatry (1979) 0.87
Waldenström's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium. Neurology (1985) 0.87
Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study. Ann Neurol (1983) 0.85
[Neuritic form of macroglobulinemia of Waldenström]. Bull Mem Soc Med Hop Paris (1959) 0.81
Immunocytochemical studies of serum proteins and immunoglobulins in human sural nerve biopsies. Acta Neuropathol (1985) 0.81
[Dysglobulinemic neuropathies]. Rev Neurol (Paris) (1988) 0.81
[Polyneuropathies with IgM monoclonal gammopathy. 12 cases]. Rev Neurol (Paris) (1987) 0.80
Peripheral neuropathy in IgM kappa paraproteinaemia: clinical and ultrastructural studies in two patients. Clin Exp Neurol (1985) 0.79
Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient. Acta Neuropathol (1986) 0.79
Dysglobulinemic neuropathy: absence of immunoglobulin within myelin sheaths. Ann Neurol (1986) 0.79
[The neuropathies of monoclonal gammapathies. Immunofluorescence and immunolabelling in the electron microscopy of immunoglobulins with amyloid structure (author's transl)]. Acta Neuropathol (1978) 0.79
Binding of swine IgM immunoglobulins to peripheral nerve myelin sheaths in electron microscopic immunocytochemistry. Acta Neuropathol (1988) 0.79
Anti-MAG IgM antibodies in patients with neuropathy and IgM M proteins: detection by ELISA. Neurology (1983) 0.77
[Pathology of polyneuropathies]. Internist (Berl) (1984) 0.77
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Ribonucleic acid composition of bacteria as a function of growth rate. J Mol Biol (1966) 3.48
Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42
Phylogeny of some Fusarium species, as determined by large-subunit rRNA sequence comparison. Mol Biol Evol (1989) 3.28
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology (2000) 2.28
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol (1998) 1.56
Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol (2005) 1.53
Isolated internal ophthalmoplegia associated with IgG anti-GQ1b antibody. Neurology (1998) 1.52
Widespread dilatation of perivascular spaces: a leukoencephalopathy causing dementia. Neurology (1997) 1.50
[Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities]. Rev Neurol (Paris) (1991) 1.47
Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease? J Neurol (2001) 1.45
Primary Langerhans' cell histiocytosis of the central nervous system with fatal outcome. Case report. J Neurosurg (1996) 1.42
CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol (1996) 1.41
Lead poisoning from the beauty case: neurologic manifestations in an elderly woman. Neurology (2007) 1.40
Single fiber EMG and spectral analysis of surface EMG in myotonia congenita with or without transient weakness. Muscle Nerve (1994) 1.39
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol (1978) 1.35
Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology (1983) 1.33
Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol (2009) 1.27
Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med (1997) 1.23
Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol (1991) 1.20
Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol (2004) 1.19
Auditory agnosia and auditory spatial deficits following left hemispheric lesions: evidence for distinct processing pathways. Neuropsychologia (2000) 1.17
Oculopharyngeal muscular dystrophy. A case with abnormal mitochondria and "fingerprint" inclusions. J Neurol Sci (1974) 1.17
Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum Mol Genet (1992) 1.14
Cloning of the nitrate reductase gene (niaD) of Aspergillus nidulans and its use for transformation of Fusarium oxysporum. Gene (1989) 1.14
Occurrence of polyglucosan bodies in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1992) 1.12
Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family. Neurology (1997) 1.11
TNF-alpha expression in painful and nonpainful neuropathies. Neurology (2001) 1.11
Human monoclonal antibodies to myelin-associated glycoprotein. Comparison of specificity and use for immunocytochemical localisation of the antigen. J Neuroimmunol (1983) 1.10
Guillain-Barré syndrome and Hodgkin's disease--ultrastructural study of a peripheral nerve. J Neurol Sci (1980) 1.10
High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology (2006) 1.10
Familial idiopathic striopallidodentate calcifications. Neurology (1989) 1.10
Analysis of the prion protein gene in thalamic dementia. Neurology (1992) 1.09
Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (1999) 1.09
[Metabolism of ribonucleic acids in Escherichia coli deficient in phosphate]. Bull Soc Chim Biol (Paris) (1967) 1.04
Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am J Pathol (2000) 1.03
[Post-radiotherapy anterior horn cell syndrome]. Rev Neurol (Paris) (1985) 1.02
Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol (2000) 1.02
Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology (2003) 1.00
Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits. Neuropathol Appl Neurobiol (1998) 1.00
Chronic demyelinating neuropathy with IgM-producing lymphocytes in peripheral nerve and delayed appearance of "benign" monoclonal gammopathy. Neurology (1984) 0.99
Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet (1999) 0.98
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg (1997) 0.97
Late central demyelination after Fischer's syndrome: MRI studies. J Neurol Neurosurg Psychiatry (1993) 0.97
Demyelination in experimental canine distemper virus infection: immunological, pathologic, and immunohistological studies. Acta Neuropathol (1982) 0.97
Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology (1988) 0.97
[Rigid forms of Huntington's disease (study of a family with an anatomo-clinical case)]. Rev Neurol (Paris) (1968) 0.96
[Peripheral neuropathies caused by diabetes mellitus. Ultrastructural study of 12 biopsied cases]. J Neurol Sci (1973) 0.95
Asymptomatic central pontine myelinolysis. Neurology (1999) 0.94
[Familial amyloid neuropathies in 3 families of French origin]. Rev Neurol (Paris) (1983) 0.94
Inflammatory demyelinating lesions in two patients with IgM monoclonal gammopathy and polyneuropathy. Neuropathol Appl Neurobiol (1991) 0.94
[Hypermyelination in a case of peripheral neuropathy with benign IgM monoclonal gammopathy]. Rev Neurol (Paris) (1985) 0.93
Dementia of frontal lobe type due to adult polyglucosan body disease. J Neurol (1995) 0.93
Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology (1988) 0.92
[Ultrastructural study of pheripheral nerve in 16 diabetics without neuropathy. Comparisons with 16 diabetic neuropathies and 16 non-diabetic neuropathies (author's transl)]. Acta Neuropathol (1974) 0.92
Indication of a possible role in a demyelinating neuropathy for an antigen shared between myelin and NK cells. Lancet (1984) 0.92
Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification. J Neurol (1990) 0.92
Neuronal apoptosis in fatal familial insomnia. Brain Pathol (1998) 0.92
TWINKLE gene mutation: report of a French family with an autosomal dominant progressive external ophthalmoplegia and literature review. Eur J Neurol (2010) 0.92
Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks' implantation in the rat--influence of the complement. J Microencapsul (1990) 0.91
[Peripheral neuropathies i- Waldenstrom's disease. Histological and ultrastructural studies of 5 cases]. Ann Anat Pathol (Paris) (1976) 0.91
Myopathy and cerebellar syndrome during acute poisoning with lithium carbonate. Muscle Nerve (1980) 0.91
Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat. Hum Mol Genet (1996) 0.91
Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol (1999) 0.91
Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection. Acta Neuropathol (1982) 0.90
Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J Clin Microbiol (1996) 0.90
Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol (1988) 0.90
The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein. J Neurochem (1990) 0.90
[Intermittent paraparesis as manifestation of a bilateral chronic subdural hematoma]. Schweiz Med Wochenschr (1999) 0.89
Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside. J Neurol (1989) 0.89
[Current incidence of herpetic encephalitis in adults: on a personal series of 8 cases confirmed by electron microscopy]. Bull Acad Natl Med (1968) 0.89
Phosphorylation of myelin basic protein. J Biol Chem (1974) 0.89
The clinical significance of diffusion-weighted MR imaging in infratentorial strokes. Neurology (2004) 0.89
Inclusion body myositis. Clinical, biological and ultrastructural study. J Neurol Sci (1982) 0.88
Squamous cell carcinoma developing in an intracranial prepontine epidermoid cyst. Ann Pathol (2000) 0.88
The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology (1993) 0.88
Paraproteinaemic neuropathies. Baillieres Clin Neurol (1996) 0.88
Guillain-Barré syndrome occurring in two women after ketoacidosic comatose state disclosing an insulin-dependent diabetes mellitus. J Peripher Nerv Syst (2000) 0.88
Polyarteritis nodosa and peripheral neuropathy. Ultrastructural study of 13 cases. Acta Neuropathol (1985) 0.88